机械取栓治疗大血管闭塞性急性缺血性脑卒中的研究进展。

Q3 Engineering

Critical Reviews in Biomedical Engineering Pub Date : 2021-01-01 DOI:10.1615/critrevbiomedeng.2022042563

M. Kameda-Smith, A. M. Pai, Y. Jung, T. Duda, B. van Adel

{"title":"机械取栓治疗大血管闭塞性急性缺血性脑卒中的研究进展。","authors":"M. Kameda-Smith, A. M. Pai, Y. Jung, T. Duda, B. van Adel","doi":"10.1615/critrevbiomedeng.2022042563","DOIUrl":null,"url":null,"abstract":"Acute ischemic stroke (AIS) is a significant cause of global morbidity and mortality, with functional implications for quality of life and long-term disability. The limitations of intravenous thrombolytic therapy for the treatment of AIS, especially for emergent large vessel occlusion (ELVO), have paved the way for alternative therapies and the rapidly evolving landscape of endovascular therapy (EVT). Here, we summarize the major landmark trials that have advanced the field largely due to ongoing biomedical engineering device development that have translated into significantly improved clinical outcomes. Our review describes the clinical success of EVT, and current and future trends.","PeriodicalId":53679,"journal":{"name":"Critical Reviews in Biomedical Engineering","volume":"49 5 1","pages":"13-70"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Advances in Mechanical Thrombectomy for Acute Ischemic Stroke Due to Large Vessel Occlusion.\",\"authors\":\"M. Kameda-Smith, A. M. Pai, Y. Jung, T. Duda, B. van Adel\",\"doi\":\"10.1615/critrevbiomedeng.2022042563\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Acute ischemic stroke (AIS) is a significant cause of global morbidity and mortality, with functional implications for quality of life and long-term disability. The limitations of intravenous thrombolytic therapy for the treatment of AIS, especially for emergent large vessel occlusion (ELVO), have paved the way for alternative therapies and the rapidly evolving landscape of endovascular therapy (EVT). Here, we summarize the major landmark trials that have advanced the field largely due to ongoing biomedical engineering device development that have translated into significantly improved clinical outcomes. Our review describes the clinical success of EVT, and current and future trends.\",\"PeriodicalId\":53679,\"journal\":{\"name\":\"Critical Reviews in Biomedical Engineering\",\"volume\":\"49 5 1\",\"pages\":\"13-70\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical Reviews in Biomedical Engineering\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1615/critrevbiomedeng.2022042563\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Engineering\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Reviews in Biomedical Engineering","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1615/critrevbiomedeng.2022042563","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Engineering","Score":null,"Total":0}

引用次数: 0

摘要

急性缺血性中风(AIS)是全球发病率和死亡率的重要原因，对生活质量和长期残疾具有功能影响。静脉溶栓治疗AIS的局限性，特别是急诊大血管闭塞(ELVO)，为替代疗法和血管内治疗(EVT)的快速发展铺平了道路。在这里，我们总结了主要的具有里程碑意义的试验，这些试验在很大程度上是由于正在进行的生物医学工程设备的发展，这些设备已经转化为显著改善的临床结果。我们的综述描述了EVT的临床成功，以及目前和未来的趋势。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Advances in Mechanical Thrombectomy for Acute Ischemic Stroke Due to Large Vessel Occlusion.

Acute ischemic stroke (AIS) is a significant cause of global morbidity and mortality, with functional implications for quality of life and long-term disability. The limitations of intravenous thrombolytic therapy for the treatment of AIS, especially for emergent large vessel occlusion (ELVO), have paved the way for alternative therapies and the rapidly evolving landscape of endovascular therapy (EVT). Here, we summarize the major landmark trials that have advanced the field largely due to ongoing biomedical engineering device development that have translated into significantly improved clinical outcomes. Our review describes the clinical success of EVT, and current and future trends.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Critical Reviews in Biomedical Engineering Engineering-Biomedical Engineering

CiteScore

1.80

自引率

0.00%

发文量

期刊介绍： Biomedical engineering has been characterized as the application of concepts drawn from engineering, computing, communications, mathematics, and the physical sciences to scientific and applied problems in the field of medicine and biology. Concepts and methodologies in biomedical engineering extend throughout the medical and biological sciences. This journal attempts to critically review a wide range of research and applied activities in the field. More often than not, topics chosen for inclusion are concerned with research and practice issues of current interest. Experts writing each review bring together current knowledge and historical information that has led to the current state-of-the-art.